Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Anticipated CAGR of the Albumin Market, and What Factors Will Drive It?

The scale of the albumin market has seen substantial expansion in the past few years. It is projected to rise from $6.57 billion in 2024 to approximately $7.18 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.3%. The expansion seen during the historical timeframe is linked to progression in biotechnology, ascending demand for therapies derived from plasma, widening use in the pharmaceutical sector, high incidence of liver disorders, regulatory sanctioning of albumin-based goods, and an increasingly globalized healthcare system that allows for broader market reach.

The market size of albumin is projected to witness robust expansion in the upcoming years, with predictions showing growth to $10.16 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the forecast period include a rise in liver disease cases, usage in regenerative medicine, a growing elderly populace, advancements in diagnostic methods, a tilt in healthcare structure towards outpatient care, and an increasing understanding of the necessity of maintaining ideal protein levels. Prominent trends for the predicted timeline include wider therapeutic usage, increased implementation in drug delivery systems, escalating demand in cell culture media, progress in personalized medicine, breakthroughs in recombinant technology, heightened awareness about managing hypoalbuminemia, and noteworthy investments in researching and developing state-of-the-art albumin-based solutions.

Which Factors Are Enhancing the Growth of the Albumin Market?

The growth of the albumin market is anticipated to be driven by the increasing prevalence of diabetes. Diabetes is a metabolic disorder characterized by persistent high levels of blood sugar. Contributing factors to the surge in diabetes cases include poor nutrition, insufficient physical activity, hormonal imbalances, and obesity. In the context of diabetes, albumin serves as a crucial biomarker, informing insulin therapy, tracking glycemic control, assisting in diagnosis, and forecasting complications like diabetic ketoacidosis (DKA). It is vital to maintain normal albumin levels for comprehensive diabetes management. For example, in January 2022, the National Library of Medicine, a government library in the US, reported that in 2021, the worldwide prevalence of diabetes was estimated at 10.5%, affecting roughly 536.6 million people aged between 20 and 79. This number is expected to rise to 12.2% by 2045, affecting about 783.2 million individuals. Therefore, the increasing prevalence of diabetes is likely to accelerate the growth of the albumin market.

Explore Comprehensive Insights Into The Global Albumin Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

Who Are the Top Companies Contributing to the Growth of the Albumin Market?

Major companies operating in the albumin market are:

• Bristol-Myers Squibb Company

• Thermo Fisher Scientific Inc.

• Takeda Pharmaceutical Company Limited

• Merck KGaA

• Baxter International Inc.

How Are Technological Trends Affecting the Growth and Development of the Albumin Market?

In the albumin market, principal corporations are focusing on the invention of cutting-edge products such as animal- and human-origin-free recombinant albumin to meet the progressive needs of its users. Recombinant albumin free from animal and human origin implies albumin produced through non-mammalian expression systems like yeast, excluding any elements from animals or humans. A particular example is the collaboration between Albumedix, a UK-based recombinant human albumin (rHA) producer, and Heartseed Inc., a Japanese biotech firm in its clinical phase, in March 2023, to introduce Recombin. This essential excipient is used in the creation of Heartseed’s experimental cell therapy, HS-001, as its pioneer human clinical trial starts. This joint venture is a critical leap in the evolution of HS-001, predicted to significantly alter the curing process for multiple diseases. Incorporating recombination in the production process ensures superior stability and performance of the cell therapy, thereby enhancing its likelihood of therapeutic triumph.

Secure Your Global Albumin Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Which Growth-Oriented Segments of the Albumin Market Are Leading the Industry’s Development?

The albumin market covered in this report is segmented –

1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin

2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications

3) By Sales Channel: Business-To-Consumer (B2C), Business-To-Business (B2B)

4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes

Subsegments:

1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin, Recombinant Human Serum Albumin, Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns), Human Serum Albumin For Drug Delivery And Research Applications

2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture), Bovine Serum Albumin For Diagnostic Kits, Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals

3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications, Recombinant Albumin For Biopharmaceutical Formulation, Recombinant Albumin For Cosmetic And Personal Care Applications, Recombinant Albumin For Research And Diagnostic Applications

What Are the Key Regions Powering Growth in the Albumin Market?

North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Albumin Market Defined Across Different Regions?

Albumin is a type of protein found in blood plasma, serum, muscle, the whites of eggs, milk, and other animal substances, as well as in many plant tissues and fluids. It is a simple, heat-coagulable, and water-soluble protein that plays a crucial role in maintaining fluid balance and transporting hormones, vitamins, and enzymes throughout the body.

Browse Through More Similar Reports By The Business Research Company:

Stem Cell Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Metagenomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Glycomics or Glycobiology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: